Assessing QbTest Utility in ADHD: A Randomised Controlled Trial

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)

Keywords

ADHD, QB Test, Activity, Attention, Children, Clinical Decision Making

Brief summary

Attention Deficit/Hyperactivity Disorder (ADHD)is one of the most common mental health disorders of childhood. Children with ADHD often have poor attention, are restless and hyperactive and show impulsive behaviour. It is important to detect ADHD so young people can have access to appropriate clinical interventions. One of the most common ways ADHD is assessed is through the clinician's opinion; however, this can vary between clinicians and is thought to be one reason why ADHD may be mis-diagnosed. Using a more objective computer tasks may help improve our understanding of ADHD. One computer task is the QbTest. The test presents different symbols to the child, and the child has to respond by pressing a button only when a target symbol appears. The test measures the child's attention, impulsivity and movement whilst doing this task. Although the test is thought to be a valid measure, more research needs to be conducted on this measure to see whether it helps clinicians decision making. To see whether this test helps clinicians make a diagnosis of ADHD and helps with medication decisions, children and young people will be asked to complete the task as part of their initial assessment for ADHD. Half the participants and their clinician will have access to the QbTest result; the other half will not have access to the QbTest result until the end of the study. Participant's parents, teachers and the clinician will also be asked to complete some questionnaires about the child's symptoms and behaviour. If the child is diagnosed with ADHD and is given medication they will be asked to complete the task again on medication. The same set of questionnaires will be completed by the parents/teachers/clinicians. The entire sample will be followed up at 6 months and asked to complete the questionnaires.

Hollis C, Hall CL, Guo B, James M, Boadu J, Groom MJ, Brown N, Kaylor-Hughes C, Moldavsky M, Valentine AZ, Walker GM, Daley D, Sayal K, Morriss R, the AQUA Trial Group.

2018-04-2640 citations

10.1111/jcpp.12921

Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach.

Hall CL, Valentine AZ, Walker GM, Ball HM, Cogger H, Daley D, Groom MJ, Sayal K, Hollis C.

2017-02-1023 citations

10.1186/s12888-017-1222-5

Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD—‘ A ssessing Q bTest U tility in A DHD’ (AQUA): a randomised controlled trial

Charlotte L Hall, Gemma Walker, Althea Valentine, Boliang Guo, Catherine Kaylor‐Hughes et al. (9 authors)

BMJ Open2014-12-0125 citations

10.1136/bmjopen-2014-006838

Interventions

OTHERQb Test

Given to all participants but the results will be open or blind depending on arm allocation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

6 Years to 17 Years

Healthy volunteers

No

Inclusion criteria

* Age 6-17 years (may turn 18 years during the study). * Referred to CAMHS or community paediatrics for an ADHD assessment * Capable of providing written informed consent (over 16) * Parental consent (under 16)

Exclusion criteria

* Non-fluent English * Suspected moderate or severe learning disability * Previous or current diagnosis of ADHD

Design outcomes

Primary

Measure	Time frame	Description
Number of clinic appointments until correct diagnosis confirmed	By 6 months	Number of clinic appointments until correct ADHD diagnosis is confirmed or excluded for the QBOpen (delivery of immediate QbTest feedback report) and QbBlind (delayed feedback of QbTest report) groups.

Secondary

Measure	Time frame	Description
Time to confirmation or exclusion of ADHD diagnosis (in days) and duration of clinic visits (in minutes).	Up to 6 months	Time to confirmation or exclusion of ADHD diagnosis (in days) and duration of clinic visits (in minutes). This will provide supporting evidence that a reduced number of clinic visits is associated with shorter overall time to diagnosis and reduced clinic time required for assessment.

Other

Measure	Time frame	Description
Degree of Confidence of diagnosis	Up to 6 months	Differences in degree of confidence of diagnosis between cases in QbOpen (QbO) and QbBlind (QbB) group. These variables will assess the utility of QbTest in aiding diagnosis (diagnostic certainty).
Stability in diagnosis and confidence between the QbO and QbB group	Up to 6 months	Stability in diagnosis and confidence between the QbO and QbB group measured as number of patients where the primary diagnosis (ADHD confirmed or excluded) was changed at their 6 month visit to the clinic.).

Countries

United Kingdom

Outcome results

None listed